Articles From: Oculus Innovative Sciences Announces Board of Directors Restructuring Following Ruthigen IPO to Ocwen Financial to Webcast Analyst and Investor Event


2014/4/2
Board Committees Restructured Election of Lead Independent Director Changes to Corporate Governance and Compensation Practices First in a Series of Modifications Based Upon Shareholder Feedback PETALUMA, Calif., April 2, 2014 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) , today announced the closing of its subsidiary, Ruthigen, Inc.'s (Nasdaq:RTGN) , initial public offering on the NASDAQ Capital Market on March 26, 2014.
Sign-up for Oculus Innovative Sciences Announces Board of Directors Restructuring Following Ruthigen IPO investment picks
2014/2/6
PETALUMA, Calif., Feb.
Sign-up for Oculus Innovative Sciences Announces Completion of Agreements Required for IPO by Company's Subsidiary, Ruthigen, Inc. investment picks
PETALUMA, Calif., July 31, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) , today announced that the financial results for its fiscal first quarter 2014, ended June 30, 2013, will be released after the U.S. market closes on August 8, 2013.
Sign-up for Oculus Innovative Sciences Announces Fiscal First Quarter 2014 Financial Results and Conference Call investment picks
2014/1/30
PETALUMA, Calif., Jan.
Sign-up for Oculus Innovative Sciences Announces Fiscal Third Quarter 2014 Financial Results and Conference Call investment picks
2014/1/7
New three-ounce Microcyn® Skin & Wound Spray HydroGel delivers wound hydrogel to entire wound site via innovative spray application Microcyn Skin & Wound Care now available in convenient two-ounce bottle for both clinical and economical in-home patient use PETALUMA, Calif., Jan.
Sign-up for Oculus Innovative Sciences Introduces Two New Microcyn(R) Advanced Wound Care Products for U.S. Prescription Wound Care Market investment picks
2014/2/19
PETALUMA, Calif., Feb.
Sign-up for Oculus Innovative Sciences Receives Approval for Oral and Throat Infection Products in Mexico investment picks
2013/12/4
Oculus U.S Dermatology Partner, Quinnova Pharmaceuticals, Targeting U.S. Launch in Q2 2014 U.S. Double-Blind, Randomized Study for Scar Management Establishes Strong Foundation for International Approval PETALUMA, Calif., Dec.
Sign-up for Oculus Innovative Sciences Receives FDA Clearance for Microcyn(R) Scar Management HydroGel investment picks
2013/12/30
PETALUMA, Calif., Dec.
Sign-up for Oculus Innovative Sciences Receives Notification of Compliance With the Stockholders' Requirement of the NASDAQ Listing Rules investment picks
2014/2/13
Microcyn® Scar Management HydroGel Approved by FDA in U.S. and Ministry of Health in Mexico During Quarter Reduced $3.0 Million Debt-Related Liability During Quarter to $50,000 Signed Internal Agreements with Ruthigen, Enabling IPO and Capping Reimbursable IPO-Related Expenses Conference Call Begins at 4:30 p.m. (ET) Today PETALUMA, Calif., Feb.
Sign-up for Oculus Innovative Sciences Reports Revenues of $3.3 Million for Third Quarter of Fiscal 2014 investment picks
EBITDAS for first quarter was ($713,000), which includes $477,000 of Ruthigen-related expenses in the quarter Oculus' wholly owned subsidiary, Ruthigen, files a registration statement on Form S-1A on August 8, 2013 Cash position of $5.4 million at June 30, 2013 Conference Call Begins at 4:30 p.m. (EDT) Today PETALUMA, Calif., Aug.
Sign-up for Oculus Innovative Sciences Reports Revenues of $3.4 Million for First Quarter of Fiscal 2014 investment picks
2013/11/19
EBITDAS for Second Quarter Was ($882,000), Including $994,000 of Ruthigen-Related Expenses in the Quarter, Resulting in a Positive EBITDAS of $112,000 on a Pro Forma Basis, Excluding Ruthigen Expenses PETALUMA, Calif., Nov.
Sign-up for Oculus Innovative Sciences Reports Revenues of $4.1 Million for Second Quarter of Fiscal 2014, Meeting Guidance of Greater Than $3.6 Million investment picks
2013/12/4
PETALUMA, Calif., Dec.
Sign-up for Oculus Innovative Sciences, Inc. Announces $2.2 Million Securities Offering investment picks
2014/2/21
PETALUMA, Calif., Feb.
Sign-up for Oculus Innovative Sciences, Inc. to Raise $1.35 Million in Registered Direct Offering investment picks
2014/2/27
By Everdeen Mason Ocwen Financial Corp.
Sign-up for Ocwen Earnings Rise 60% investment picks
2014/2/27
Q4 Net income of $105 million and Revenue of $556 million Full-year 2013 Net income of $294 million and EPS of $2.02    ATLANTA, Feb.
Sign-up for Ocwen Financial Announces Operating Results for Fourth Quarter and Full Year 2013 investment picks
ATLANTA, Aug.
Sign-up for Ocwen Financial Announces Operating Results for Second Quarter 2013 investment picks
2013/10/31
Revenue More Than Doubles to $531.2 Million $500 Million Share Repurchase Program Announced ATLANTA, Oct.
Sign-up for Ocwen Financial Announces Operating Results for Third Quarter 2013 investment picks
Levi & Korsinsky, LLP is investigating Ocwen Financial Corp.
Sign-up for Ocwen Financial Corp. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ocwen Financial Corp. investment picks
2013/12/4
Levi & Korsinsky, LLP is investigating Ocwen Financial Corp.
Sign-up for Ocwen Financial Corp. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ocwen Financial Corp. investment picks
2014/3/11
NEW YORK , March 11, 2014 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Ocwen Financial Corp.
Sign-up for Ocwen Financial Corp. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ocwen Financial Corp. investment picks
2014/2/12
ATLANTA, Feb.
Sign-up for Ocwen Financial Corporation Schedules Conference Call - 4th Quarter / Year End 2013 Results investment picks
2013/7/23
ATLANTA, July 23, 2013 (GLOBE NEWSWIRE) -- Ocwen Financial Corporation (NYSE:OCN) will hold its conference call on Thursday, August 1, 2013 at 11:00 a.m. (ET) to review the Company's operating results.
Sign-up for Ocwen Financial Corporation Schedules Conference Call -- 2nd Quarter 2013 Results investment picks
2014/2/6
ATLANTA, Feb.
Sign-up for Ocwen Financial Corporation Update investment picks
ATLANTA, Nov.
Sign-up for Ocwen Financial to Webcast Analyst and Investor Event investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Oculus Innovative Sciences Announces Board of Directors Restructuring Following Ruthigen IPO to Ocwen Financial to Webcast Analyst and Investor Event
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity